Subunits of the IL-17 receptor complex CoULD for l Soluble antagonists BI6727 that several members that bind to IL 17A and IL-17F can design. IL 17 results Ans PageSever are eagerly anticipated for a variety of indications, including rheumatoid arthritis And with psoriasis. The family of interleukin 12: Regulation of T-cell differentiation IL 12 and IL 23 are related cytokines, which are secreted by macrophages and dendritic cells after cytokine stimulation or without a receptor ligand. IL 12 is an essential triggering Water of Th1 cells producing CD4 T gamma interferon, w While IL 23 tr # adds to polarize Th17. Thus k Nnte targeted therapy IL 23 is a downstream effect on the production of IL 17th When T-cells are exposed to IL 23, k Cells may in the direction of Th17 Ph Be directed phenotype.
This is especially true in M Nozzles, where the JNJ-7706621 exposure to IL-6 and transforming growth factor beta production of Th17 cells thanks tr gt To STAT3 activation and induction of the transcription factor retino S Ure As related orphan receptor. System in humans is not as well defined and TGF  light not help m. However, k Nnte affect a targeted therapy IL 23 Downstream rts limiting Th17 cell activation and reduces the expression of IL Family 17 The interaction between IL 12 and IL 23 and Autoimmunit t Can be complex, erh Ht deficient M Usen in IL 12 p35 subunit of the severity of CIA. In contrast, the Mice which p19 subunit of IL 23 by the CIA, and knockout-M nozzles p40 subunit be jointly protected IL 12 and IL 23rd W During IFN  signature cytokine of Th1 cells and pathogens in some models of Autoimmunit t, including normal proteoglycan-induced arthritis, the IL 12/IFN xis may also have a protective effect of the CIA and experimental allergic encephalomyelitis.
IFN  o lso  Bl press Th17 development and m can improve May receive the response of regulatory T cells. Strategies st with IL 17 Ren IL 23 production 12/IL inhibitors or IFN  an o  potentiate the suppressive activity t of Tregs and Autoimmunit t limit. The number of cells may also Treg with modulators of other cytokines, such as infliximab erh hen. Apparent inverse ratio Ratio of Treg and Th17 cells provide an m Glicher way to modify the immune response to ver Hom and restoration of homeostasis Through the modulation of cytokines. IFN  oi s expressed at relatively low levels in rheumatoid synovium With and exerts anti-inflammatory effects in vitro and in some models of arthritis.
IFN  dministration in rheumatoid arthritis Look minimally effective and aggravation caused in multiple sclerosis. Patient k Can not tolerate a dose much lower than that required to suppress arthritis in mouse models. Based on the results of pr Clinical and clinical studies, a selective agent was 12 IT manages the st Rt Th1 cell differentiation, without large en m affect Th17 cells May receive less attractive. The mouse and human T-cell systems differ significantly in many ways, making it difficult to extrapolate from mouse models. As noted above, TGF usen crucial for Th17 differentiation in M, But the technique may be less important in human cells. A large percentage of it to produce human IL 17 positive T cells and IFN When blocking Th17 cells sufficiently M Can be usen, efficacy may require removal of both Th1 and Th17 pathways in humans.